X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4457) 4457
Book Review (1119) 1119
Publication (335) 335
Newsletter (167) 167
Book Chapter (21) 21
Newspaper Article (9) 9
Book / eBook (7) 7
Conference Proceeding (6) 6
Dissertation (3) 3
Magazine Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3612) 3612
humans (3222) 3222
candidiasis (1808) 1808
female (1447) 1447
male (1402) 1402
antifungal agents - therapeutic use (1341) 1341
infectious diseases (1220) 1220
microbiology (1203) 1203
epidemiology (1018) 1018
candidiasis - drug therapy (979) 979
invasive candidiasis (976) 976
candidiasis - microbiology (955) 955
middle aged (938) 938
adult (917) 917
mortality (876) 876
risk factors (875) 875
antifungal agents (860) 860
fluconazole (841) 841
candida (786) 786
candidemia (773) 773
aged (743) 743
health aspects (740) 740
infections (735) 735
mycoses (723) 723
animals (675) 675
risk-factors (647) 647
candida - isolation & purification (643) 643
antifungal agents - pharmacology (592) 592
blood-stream infections (587) 587
research (565) 565
pharmacology & pharmacy (560) 560
candidiasis - epidemiology (555) 555
mycology (530) 530
immunology (529) 529
candida albicans (507) 507
fungal-infections (501) 501
amphotericin-b (469) 469
fungal infections (463) 463
infant, newborn (461) 461
retrospective studies (461) 461
adolescent (455) 455
diagnosis (451) 451
care and treatment (445) 445
microbial sensitivity tests (443) 443
candidiasis - diagnosis (441) 441
infection (434) 434
candida - drug effects (430) 430
child (405) 405
treatment outcome (404) 404
mice (403) 403
fungi (400) 400
analysis (388) 388
aspergillosis (388) 388
candida - classification (384) 384
pediatrics (380) 380
intensive-care-unit (379) 379
albicans (376) 376
aged, 80 and over (348) 348
infant (347) 347
incidence (343) 343
antifungal agents - administration & dosage (333) 333
fluconazole - therapeutic use (327) 327
management (322) 322
drug therapy (320) 320
intensive care units (309) 309
therapy (306) 306
candidiasis - mortality (303) 303
child, preschool (303) 303
drug resistance, fungal (299) 299
internal medicine (293) 293
caspofungin (287) 287
echinocandins (287) 287
mycoses - drug therapy (285) 285
surveillance (285) 285
abridged index medicus (279) 279
amphotericin b (279) 279
critically-ill patients (277) 277
young adult (268) 268
antifungal susceptibility (266) 266
prospective studies (262) 262
amphotericin b - therapeutic use (260) 260
yeast (260) 260
candidiasis - prevention & control (258) 258
colonization (256) 256
medicine & public health (253) 253
liposomal amphotericin-b (250) 250
research article (244) 244
echinocandins - therapeutic use (241) 241
hospitals (240) 240
transplantation (240) 240
voriconazole (238) 238
candidiasis - immunology (237) 237
infectious disease (229) 229
virulence (229) 229
antifungal therapy (222) 222
candida albicans - drug effects (221) 221
infants (221) 221
resistance (220) 220
immunocompromised host (215) 215
medical microbiology (215) 215
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4433) 4433
Spanish (114) 114
German (40) 40
French (34) 34
Portuguese (10) 10
Polish (5) 5
Czech (4) 4
Japanese (4) 4
Chinese (3) 3
Estonian (3) 3
Italian (3) 3
Korean (3) 3
Russian (3) 3
Indonesian (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Danish (1) 1
Dutch (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 2/2012, Volume 54, Issue 4, pp. 502 - 510
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2017, Volume 17, Issue 1, pp. 481 - 481
Background: Cost-effectiveness studies of echinocandins for the treatment of invasive candidiasis, including candidemia, are rare in Asia. No study has... 
Echinocandin | Pharmacoeconomics | Antifungal therapy | Candidemia | Anidulafungin | Fluconazole | COST-EFFECTIVENESS ANALYSIS | CASPOFUNGIN | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | GUIDELINE | RECOMMENDATIONS | EPIDEMIOLOGY | Candida albicans - pathogenicity | Economics, Pharmaceutical | Lipopeptides - therapeutic use | Humans | Treatment Outcome | Candidemia - mortality | Antifungal Agents - economics | Candidemia - economics | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Candidiasis, Invasive - mortality | Candida albicans - drug effects | Candida - pathogenicity | Candidemia - drug therapy | Candidiasis, Invasive - economics | Echinocandins - economics | Lipopeptides - economics | Cost-Benefit Analysis | Fluconazole - economics | Candidiasis, Invasive - drug therapy | Taiwan | Echinocandins - therapeutic use | Candida - drug effects | Economic aspects | Candidiasis | Dosage and administration | Research | Drug therapy | Antifungal agents | Health care | Intensive care | Fungicides | Medical services | Clinical trials | Infections | Epidemiology | Success | Clinical outcomes | Fungi | Caspofungin | Drug dosages | Economics | Medical research | Sensitivity analysis | Mortality | Acne | Health care policy | Pharmacology | Micafungin | Construction costs | Studies | Sensitivity | Infectious diseases | Hospitals | Echinocandins | Cost analysis | Index Medicus
Journal Article
Medicine, ISSN 0025-7974, 06/2019, Volume 98, Issue 23, pp. e15933 - e15933
Invasive candidiasis (IC) is a major cause of morbimortality in children. Previous studies described the clinical characteristics and risk factors for this... 
MANAGEMENT | CANDIDEMIA EPIDEMIOLOGY | SUSCEPTIBILITY | invasive candidiasis | FRANCE | pediatric | FUNGAL-INFECTIONS | CHILDREN | MEDICINE, GENERAL & INTERNAL | Candida | INFANTS | DISEASE | mortality | intensive care unit | HEALTH | BIOFILM FORMATION | Death | Candidiasis | Children | Patient outcomes | Risk factors | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 09/2011, Volume 11, Issue 1, pp. 261 - 261
Journal Article
Journal Article
Mycoses, ISSN 0933-7407, 07/2015, Volume 58, Issue 7, pp. 399 - 407
Journal Article
Mycoses, ISSN 0933-7407, 02/2017, Volume 60, Issue 2, pp. 118 - 123
To describe the epidemiology of invasive Candida infection in a tertiary care paediatric hospital. Prospective single-centre survey on all Candida strains... 
paediatrics | prospective single-centre study | invasive fungal disease | Candida | urinary tract infection | UNITED-STATES | MULTICENTER | RISK-FACTORS | SUSCEPTIBILITY | DERMATOLOGY | ITALIAN INSTITUTION | EXPERIENCE | MYCOLOGY | MYCOSES | BLOOD-STREAM INFECTIONS | EPIDEMIOLOGY | Prospective Studies | Urinary Tract Infections - mortality | Humans | Candidiasis - epidemiology | Infant | Male | Candidiasis - microbiology | Fungemia - mortality | Antifungal Agents - therapeutic use | Candidiasis, Invasive - mortality | Neoplasms - complications | Peritonitis - microbiology | Fungemia - drug therapy | Candida albicans - isolation & purification | Candidiasis, Invasive - drug therapy | Female | Urinary Tract Infections - microbiology | Child | Infant, Newborn | Infant, Low Birth Weight | Tertiary Care Centers | Candidiasis, Invasive - epidemiology | Neoplasms - microbiology | Risk Factors | Candidiasis - mortality | Peritonitis - epidemiology | Fungemia - microbiology | Candida - isolation & purification | Peritonitis - mortality | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Adolescent | Fungemia - epidemiology | Peritonitis - drug therapy | Candidiasis, Invasive - microbiology | Neonates | Berries | Invasiveness | Mortality | Urinary tract infections | Birth weight | Urinary tract | Children | Urogenital system | Peritonitis | Urinary tract diseases | Cancer
Journal Article
Journal of Infection, ISSN 0163-4453, 2017, Volume 74, Issue 4, pp. 408 - 417
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 5, pp. 604 - 610
Journal Article
Journal of Infection, ISSN 0163-4453, 2015, Volume 72, Issue 1, pp. 29 - 35
Summary Objectives The objective of this study was to investigate the prognostic potential of 1,3-beta- d -glucan (BDG) testing in bronchoalveolar lavage fluid... 
Infectious Disease | BDG | Mortality | 90-Day | ICU | BAL | Survival | 30-Day | Prognostic | INFECTIOUS DISEASES | VENTILATOR-ASSOCIATED PNEUMONIA | BETA-D-GLUCAN | FUNGAL-INFECTIONS |